| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Interrelation of coronary calcification, myocardial ischemia, and outcomes in patients with intermediate likelihood of coronary artery disease: a combined positron emission tomography/computed tomography study.
|
Circulation
|
2008
|
2.77
|
|
2
|
Patient management after noninvasive cardiac imaging results from SPARC (Study of myocardial perfusion and coronary anatomy imaging roles in coronary artery disease).
|
J Am Coll Cardiol
|
2012
|
2.60
|
|
3
|
Association between coronary vascular dysfunction and cardiac mortality in patients with and without diabetes mellitus.
|
Circulation
|
2012
|
2.33
|
|
4
|
Improved cardiac risk assessment with noninvasive measures of coronary flow reserve.
|
Circulation
|
2011
|
2.32
|
|
5
|
Comparison of fully automated computer analysis and visual scoring for detection of coronary artery disease from myocardial perfusion SPECT in a large population.
|
J Nucl Med
|
2013
|
2.30
|
|
6
|
Quantitative relationship between the extent and morphology of coronary atherosclerotic plaque and downstream myocardial perfusion.
|
J Am Coll Cardiol
|
2011
|
2.23
|
|
7
|
Prognostic interplay of coronary artery calcification and underlying vascular dysfunction in patients with suspected coronary artery disease.
|
J Am Coll Cardiol
|
2013
|
2.11
|
|
8
|
Reproducibility and accuracy of quantitative myocardial blood flow assessment with (82)Rb PET: comparison with (13)N-ammonia PET.
|
J Nucl Med
|
2009
|
1.74
|
|
9
|
Coronary vascular dysfunction and prognosis in patients with chronic kidney disease.
|
JACC Cardiovasc Imaging
|
2012
|
1.61
|
|
10
|
Safety and feasibility of regadenoson use for suboptimal heart rate response during symptom-limited standard Bruce exercise stress test.
|
J Nucl Cardiol
|
2012
|
1.55
|
|
11
|
Influence of sex on risk stratification with stress myocardial perfusion Rb-82 positron emission tomography: Results from the PET (Positron Emission Tomography) Prognosis Multicenter Registry.
|
J Am Coll Cardiol
|
2013
|
1.54
|
|
12
|
Diagnostic accuracy of rubidium-82 myocardial perfusion imaging with hybrid positron emission tomography/computed tomography in the detection of coronary artery disease.
|
J Am Coll Cardiol
|
2007
|
1.51
|
|
13
|
Prognostic significance of impaired chronotropic response to pharmacologic stress Rb-82 PET.
|
J Nucl Cardiol
|
2014
|
1.46
|
|
14
|
Anatomic versus physiologic assessment of coronary artery disease. Role of coronary flow reserve, fractional flow reserve, and positron emission tomography imaging in revascularization decision-making.
|
J Am Coll Cardiol
|
2013
|
1.44
|
|
15
|
Clinical myocardial perfusion PET/CT.
|
J Nucl Med
|
2007
|
1.42
|
|
16
|
Value of reserve pulse pressure in improving the risk stratification of patients with normal myocardial perfusion imaging.
|
Eur Heart J
|
2013
|
1.39
|
|
17
|
Relationship between CT coronary angiography and stress perfusion imaging in patients with suspected ischemic heart disease assessed by integrated PET-CT imaging.
|
J Nucl Cardiol
|
2007
|
1.31
|
|
18
|
Right ventricular dysfunction assessed by cardiovascular magnetic resonance imaging predicts poor prognosis late after myocardial infarction.
|
J Am Coll Cardiol
|
2007
|
1.21
|
|
19
|
Incremental prognostic value of myocardial perfusion imaging in patients referred to stress single-photon emission computed tomography with renal dysfunction.
|
Circ Cardiovasc Imaging
|
2009
|
1.07
|
|
20
|
Recent advances in cardiac PET and PET/CT myocardial perfusion imaging.
|
J Nucl Cardiol
|
2009
|
1.06
|
|
21
|
Preserved coronary flow reserve effectively excludes high-risk coronary artery disease on angiography.
|
J Nucl Med
|
2014
|
1.01
|
|
22
|
Ethnic differences in the presentation, treatment strategy, and outcomes of percutaneous coronary intervention (a report from the National Heart, Lung, and Blood Institute Dynamic Registry).
|
Am J Cardiol
|
2003
|
1.00
|
|
23
|
Quantitative relationship between coronary calcium content and coronary flow reserve as assessed by integrated PET/CT imaging.
|
Eur J Nucl Med Mol Imaging
|
2009
|
1.00
|
|
24
|
Survey results: a decade of change in professional life in cardiology: a 2008 report of the ACC women in cardiology council.
|
J Am Coll Cardiol
|
2008
|
0.94
|
|
25
|
Multimodality imaging in the assessment of myocardial viability.
|
Heart Fail Rev
|
2011
|
0.94
|
|
26
|
Coronary circulatory function in patients with the metabolic syndrome.
|
J Nucl Med
|
2011
|
0.94
|
|
27
|
Cardiac PET-CT.
|
J Thorac Imaging
|
2007
|
0.93
|
|
28
|
Quantitative relation between hemodynamic changes during intravenous adenosine infusion and the magnitude of coronary hyperemia: implications for myocardial perfusion imaging.
|
J Am Coll Cardiol
|
2005
|
0.92
|
|
29
|
Reduction in ¹⁸F-fluorodeoxyglucose uptake on serial cardiac positron emission tomography is associated with improved left ventricular ejection fraction in patients with cardiac sarcoidosis.
|
J Nucl Cardiol
|
2013
|
0.90
|
|
30
|
(18)F-FDG PET/CT for the assessment of myocardial sarcoidosis.
|
Curr Cardiol Rep
|
2013
|
0.87
|
|
31
|
Quantitative relationship between coronary vasodilator reserve assessed by 82Rb PET imaging and coronary artery stenosis severity.
|
Eur J Nucl Med Mol Imaging
|
2008
|
0.87
|
|
32
|
18F-FDG PET/CT for the assessment of myocardial sarcoidosis.
|
Curr Cardiol Rep
|
2013
|
0.85
|
|
33
|
Association of electrocardiographic morphology of exercise-induced ventricular arrhythmia with mortality.
|
Ann Intern Med
|
2008
|
0.85
|
|
34
|
Detection of obstructive coronary artery disease using regadenoson stress and 82Rb PET/CT myocardial perfusion imaging.
|
J Nucl Med
|
2013
|
0.85
|
|
35
|
Improved accuracy of myocardial perfusion SPECT for the detection of coronary artery disease using a support vector machine algorithm.
|
J Nucl Med
|
2013
|
0.84
|
|
36
|
Integrated cardiac PET-CT for the diagnosis and management of CAD.
|
J Nucl Cardiol
|
2006
|
0.83
|
|
37
|
Fully automated wall motion and thickening scoring system for myocardial perfusion SPECT: method development and validation in large population.
|
J Nucl Cardiol
|
2012
|
0.83
|
|
38
|
ACR Appropriateness Criteria(®) acute nonspecific chest pain-low probability of coronary artery disease.
|
J Am Coll Radiol
|
2012
|
0.83
|
|
39
|
Myocardial perfusion imaging and multidetector computed tomographic coronary angiography: appropriate for all patients with suspected coronary artery disease?
|
J Am Coll Cardiol
|
2006
|
0.83
|
|
40
|
Assessment of myocardial perfusion and function with PET and PET/CT.
|
J Nucl Cardiol
|
2010
|
0.83
|
|
41
|
Coronary artery calcification and vascular function.
|
J Nucl Cardiol
|
2012
|
0.82
|
|
42
|
ACR Appropriateness Criteria® acute chest pain--suspected pulmonary embolism.
|
J Thorac Imaging
|
2012
|
0.81
|
|
43
|
Adding calcium scoring to myocardial perfusion imaging: Does it alter physicians' therapeutic decision making?
|
J Nucl Cardiol
|
2010
|
0.81
|
|
44
|
Quantitative relation of ST-segment depression during exercise to the magnitude of myocardial ischemia as assessed by single-photon emission computed tomographic myocardial perfusion imaging.
|
Am J Cardiol
|
2004
|
0.78
|
|
45
|
Occupational radiation dose associated with Rb-82 myocardial perfusion positron emission tomography imaging.
|
J Nucl Cardiol
|
2006
|
0.78
|
|
46
|
ACR Appropriateness Criteria chronic chest pain-low to intermediate probability of coronary artery disease.
|
J Am Coll Radiol
|
2013
|
0.78
|
|
47
|
Cardiomyopathy of uncertain etiology: Complementary role of multimodality imaging with cardiac MRI and 18FDG PET.
|
J Nucl Cardiol
|
2010
|
0.77
|
|
48
|
Reply: Cardiac positron emission tomography as a prognostic indicator of cardiac sarcoidosis.
|
J Am Coll Cardiol
|
2014
|
0.76
|
|
49
|
Clinical Role of Hybrid Imaging.
|
Curr Cardiovasc Imaging Rep
|
2010
|
0.76
|
|
50
|
Use of multimodality imaging to diagnose cardiac sarcoidosis as well as identify recurrence following heart transplantation.
|
J Nucl Cardiol
|
2013
|
0.76
|
|
51
|
Multimodality imaging of an unusual case of cardiac paraganglioma.
|
J Nucl Cardiol
|
2009
|
0.76
|
|
52
|
Advancing the research mission of ASNC.
|
J Nucl Cardiol
|
2011
|
0.75
|
|
53
|
Cardiac sarcoidosis: case report, workup, and review of the literature.
|
Cardiol Ther
|
2013
|
0.75
|
|
54
|
Reply: (18)F-FDG imaging in patients with "suspected," but not "proven," sarcoidosis.
|
J Am Coll Cardiol
|
2014
|
0.75
|
|
55
|
Pursuing an underdiagnosed disease: a simple imaging test for increasing suspicion of cardiac amyloidosis.
|
Eur J Nucl Med Mol Imaging
|
2011
|
0.75
|
|
56
|
Cardiology patient page. Exercise testing and nuclear scanning.
|
Circulation
|
2003
|
0.75
|
|
57
|
Left atrial enlargement increases the risk of major adverse cardiac events independent of coronary vasodilator capacity.
|
Eur J Nucl Med Mol Imaging
|
2015
|
0.75
|
|
58
|
Use of high-risk features from exercise treadmill testing to identify obstructive left main disease with normal myocardial perfusion imaging.
|
J Nucl Cardiol
|
2012
|
0.75
|
|
59
|
ACR appropriateness criteria® nonischemic myocardial disease with clinical manifestations (ischemic cardiomyopathy already excluded).
|
J Thorac Imaging
|
2014
|
0.75
|
|
60
|
ASNC model coverage policy: Cardiac positron emission tomographic imaging.
|
J Nucl Cardiol
|
2013
|
0.75
|
|
61
|
Ask the doctor. I recently had a nuclear stress test and contrast agent got stuck in my gut, so the image couldn't be read. Is this a common problem, and is there anything that can be done about it?
|
Harv Health Lett
|
2011
|
0.75
|
|
62
|
Correlative imaging of spontaneous coronary artery dissection.
|
J Nucl Cardiol
|
2012
|
0.75
|
|
63
|
Single photon emission computed tomography perfusion imaging for assessment of myocardial viability and management of heart failure.
|
Curr Cardiol Rep
|
2003
|
0.75
|
|
64
|
Coronary Microvascular Dysfunction Identifies Patients at High Risk of Adverse Events Across Cardiometabolic Diseases.
|
J Am Coll Cardiol
|
2017
|
0.75
|
|
65
|
QT dispersion and viable myocardium in patients with prior myocardial infarction and severe left ventricular dysfunction.
|
Ann Noninvasive Electrocardiol
|
2002
|
0.75
|